Friday, February 26, 2010

Maverick Capital’s Lee Ainslie reviews 2009 and looks ahead to 2010

Hedge fund manager Maverick Capital sent out its fourth-quarter 2009 investor letter earlier this month, detailing both Maverick’s 2009 performance and its predictions for 2010. According to the investor letter, throughout 2009 “fundamental stock-picking was a challenging endeavor as equity markets opened the year with the continuation of last year’s collapse” and as “fundamentals took a backseat to liquidity flooding out of and into the markets as well as to ballooning and collapsing risk premiums.” However, on a smaller-capital basis, “credit, small cap and private equity efforts each generated terrific returns” for Maverick. In industry-specific sectors, only consumer and healthcare generated disappointing returns, and “technology and media & telecom sectors were significant contributors” to performance. Shorting, on the other hand, provided a challenge in 2009 even though Maverick emerged with “slight gains in our short investments in Japan and the credit space.”
See the full article at:

Tuesday, February 23, 2010

Carl Icahn eyes Biotech leader Genzyme Corp

Here is an article on Carl Icahm, one my favorite shareholder activist. In in his latest activist battle, Icahn is taking on troubled biotech company Genzyme Corp.
More details on Mr. Ichan and his hedge fund firm can be out found here:

Saturday, February 20, 2010

Raising Assets in 2010: What emerging hedge funds and fund of hedge fund managers need to know

Interesting upcoming event from Emerging Manager Focus that will feature industry experts discussing strategies for hedge funds that are raising capital. For more information, please see: